|
|
Volumn 11, Issue 12, 2015, Pages 667-
|
|
In the news: Ocrelizumab excites ECTRIMS
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
OCRELIZUMAB;
PLACEBO;
BRAIN DAMAGE;
BRAIN SIZE;
DISABILITY;
DISEASE ACTIVITY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MEDICAL RESEARCH;
MULTIPLE SCLEROSIS;
NOTE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RELAPSE;
REMISSION;
RISK REDUCTION;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 84949324284
PISSN: 17594758
EISSN: 17594766
Source Type: Journal
DOI: 10.1038/nrneurol.2015.210 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
